Please login to the form below
Lars Rebien Sørensen becomes chairman of Novo Holdings
He will take up the new role 1 July
Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman.
He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector.
“I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further increase its investments in life science companies in the coming years.
Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of the board of the Novo Nordisk Foundation.
COVID-19 Updates and Daily News
Featured jobs
-
Senior External Communications Lead
-
£Competitive Salary
-
Senior Medical Writer
-
Salary TBC
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Manager
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Account Director, Medical Education
-
Salary TBC
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Senior Account Manager
-
Salary TBC
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director
-
£Competitive Salary
-
Account Director – UK Office
-
Excellent salary and benefits
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- WHO partners with WhatsApp to provide accurate COVID-19 information
- UPDATED: Gilead drops remdesivir’s orphan drug designation
- UK biotech Synairgen to begin COVID-19 trial of lead candidate
- Takeda begins development of COVID-19 plasma therapy
- Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
- Did Trump offer CureVac $1bn for COVID-19 vaccine rights?
- COVID-19 delays Pfizer, Mylan’s generics merger and spin-out
- UK contributes £210m towards COVID-19 vaccine efforts
- Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19
- In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
- COVID-19 message to clients from OPEN Health CEO, David Rowley
- The march to sustainability
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- The role of women in science and technology
- Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
- China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
- China secures a place at the forefront of innovative medicine...
- Virtual Research Grants Submission and Approval Program
- Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....
Quick links
Infographics
